View Exam | PowerPak

1. There is sufficient evidence to recommend cannabidiol (CBD) in many neurologic conditions, including which of the following disease states?

A. Parkinson's disease B. Glial blastoma C. Epilepsy D. Restless legs syndrome E. Unsure

2. Which of the following is considered a Schedule I substance by the Drug Enforcement Administration (DEA)?

A. Epidiolex B. Cannabidiol (CBD) C. Marijuana D. B and C E. Unsure

3. Epidiolex is approved for which type of epilepsy?

A. Focal onset seizures with secondary generalization B. Absence seizures C. Lennox-Gastaut syndrome and Dravet syndrome D. Juvenile myoclonic epilepsy E. Unsure

4. What agency is most concerned with marketing and labeling of cannabidiol to ensure legal and safe products are sold to persons in the United States?

A. United States Food and Drug Administration B. United States Drug Enforcement Agency C. United States Department of Agriculture D. United States Environmental Protection Agency E. Unsure

5. A 68-year-old woman with epilepsy, diabetes, and hypertension is living alone in an independent nursing home facility. She currently takes 10 different medications for these conditions. She has started using cannabidiol for sleep. Which of the following patient safety issues is most important to address with her?

A. Child-resistant packaging B. Keeping marijuana out of the reach of children C. Proper labels and warnings D. Potential drug interactions* E. Unsure

Evaluation Questions

6. How confident are you in addressing your patient safety issue with the patient in the post-test?

A. Not at all confident B. Somewhat confident C. Confident D. Highly confident

Maintenance is scheduled for 8/7/2023 7:00 AM EST - 8:00 AM EST.

{{recommendationsA.Title}}

{{recommendationsB.Title}}

1. There is sufficient evidence to recommend cannabidiol (CBD) in many neurologic conditions, including which of the following disease states?

2. Which of the following is considered a Schedule I substance by the Drug Enforcement Administration (DEA)?

3. Epidiolex is approved for which type of epilepsy?

4. What agency is most concerned with marketing and labeling of cannabidiol to ensure legal and safe products are sold to persons in the United States?

Evaluation Questions

6. How confident are you in addressing your patient safety issue with the patient in the post-test?

« Return to Activity

Maintenance is scheduled for 8/7/2023 7:00 AM EST - 8:00 AM EST.

The shopping cart is empty

Customers who Purchasedthis Activity also Purchased

{{recommendationsA.Title}}

{{recommendationsB.Title}}

1. There is sufficient evidence to recommend cannabidiol (CBD) in many neurologic conditions, including which of the following disease states?

2. Which of the following is considered a Schedule I substance by the Drug Enforcement Administration (DEA)?

3. Epidiolex is approved for which type of epilepsy?

4. What agency is most concerned with marketing and labeling of cannabidiol to ensure legal and safe products are sold to persons in the United States?

Evaluation Questions

6. How confident are you in addressing your patient safety issue with the patient in the post-test?

« Return to Activity

Customers who Purchased
this Activity also Purchased